View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2051-02-15 |
| Par Value | |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 700.73 |
| Coupon | 5.2 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 700.731 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Biogen Inc corporate bond has a 5.20% fixed rate coupon paid on a semi-annual basis. It was issued on September 15, 2020 with an issue size of 700.73 million USD and matures on February 15, 2051 with a last coupon date of August 15, 2050. |
Biogen Inc, founded in 1978 and headquartered in Cambridge, Massachusetts, is a global biotechnology company dedicated to developing innovative therapies for neurodegenerative diseases. The company's main focus includes treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease, positioning it as a leader in the biopharmaceutical industry.